{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T18:14:22Z","timestamp":1764267262620,"version":"3.46.0"},"reference-count":3,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,4,6]],"date-time":"2024-04-06T00:00:00Z","timestamp":1712361600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,4,6]],"date-time":"2024-04-06T00:00:00Z","timestamp":1712361600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hematopathol"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1007\/s12308-024-00583-w","type":"journal-article","created":{"date-parts":[[2024,4,5]],"date-time":"2024-04-05T23:25:40Z","timestamp":1712359540000},"page":"117-119","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Secondary plasma cell leukaemia (PCL) with plasmablastic morphology"],"prefix":"10.1007","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2453-4475","authenticated-orcid":false,"given":"Ke","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth","family":"Nacheva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,4,6]]},"reference":[{"key":"583_CR1","doi-asserted-by":"crossref","unstructured":"de Larrea CF et al (2021) Primary plasma cell leukemia: consensus definition by the Internatinoal Myeloma Working Group according to peripheral blood plasma cell percentage. Blood Cancer J 11(12):192","DOI":"10.1038\/s41408-021-00587-0"},{"issue":"1","key":"583_CR2","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1080\/10428194.2018.1473574","volume":"60","author":"A Jurczyszyn","year":"2019","unstructured":"Jurczyszyn A et al (2019) Secondary plasma cell leukemia: a multicenter retrospective study of 101 patients. Leuk Lymphoma 60(1):118\u2013123","journal-title":"Leuk Lymphoma"},{"issue":"7","key":"583_CR3","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.1182\/blood.v91.7.2501","volume":"91","author":"PR Greipp","year":"1998","unstructured":"Greipp PR, Leong T, Bennett JM et al (1998) Plasmablastic morphology-an independent prognostic factor with clinical and laboratory correlates: Eastern Cooperative Oncology Group (ECOG) myeloma trial e9486 report by the ECOG myeloma laboratory group. Blood 91(7):2501\u20132507. https:\/\/doi.org\/10.1182\/blood.v91.7.2501","journal-title":"Blood"}],"container-title":["Journal of Hematopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12308-024-00583-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12308-024-00583-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12308-024-00583-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T18:11:23Z","timestamp":1764267083000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12308-024-00583-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,6]]},"references-count":3,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["583"],"URL":"https:\/\/doi.org\/10.1007\/s12308-024-00583-w","relation":{},"ISSN":["1868-9256","1865-5785"],"issn-type":[{"type":"print","value":"1868-9256"},{"type":"electronic","value":"1865-5785"}],"subject":[],"published":{"date-parts":[[2024,4,6]]},"assertion":[{"value":"26 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human participants performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"For this type of study informed consent is not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"For this type of study, consent for publication is not required.\u00a0No written or verbal consent obtained from patient. Patient has passed away.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}